Abbott (NYSE:ABT) Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark ...

In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated The approval was based on a Japanese Phase 3 study and the global ...

In animal experiments, the active homolog SN-40X significantly improved systemic insulin sensitivity and glucose homeostasis in T2DM mice without significant toxicity ... developing novel drugs ...

Researchers found that HFD impaired bone marrow neutrophil's ability to store and release TNF-alpha, an immune signal important for regulating inflammation. Neutrophils from HFD mice expressed ...

Specifically, the authors demonstrate the critical role of tumor necrosis factor (TNF) signaling in SAVI in mouse model. Overall, the data presented are convincing, supporting the author's conclusions ...

The gut microbiota and its metabolic products may promote the development of T2DM by exacerbating IR ... interleukin receptor-associated kinases; TRAF6, tumor necrosis factor receptor-related ...